Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines

被引:0
作者
Zhidong Hu
Weimin Jiang
Ling Gu
Dan Qiao
Tsugumine Shu
Douglas B. Lowrie
Shui-Hua Lu
Xiao-Yong Fan
机构
[1] Fudan University,Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH
[2] Fudan University,Departments of Infectious Diseases, Huashan Hospital
[3] Wenzhou Medical University,School of Laboratory Medicine and Life Science
[4] Shanghai Emerging and Re-emerging Institute,TB Center
[5] Shanghai Jiaotong University,Ruijin Hospital (North)
[6] ID Pharma,undefined
来源
Journal of Molecular Medicine | 2019年 / 97卷
关键词
Tuberculosis; Sendai virus; DNA vaccine; Prime-boost; T cell responses;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1685 / 1694
页数:9
相关论文
共 318 条
[21]  
Berry MP(2008)DNA vaccines: developing new strategies to enhance immune responses Immunol Res 42 661-1449
[22]  
Orme IM(2011)Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice Vaccine 29 64-5368
[23]  
Robinson RT(2014)Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination Immunology 143 1435-e825
[24]  
Cooper AM(2016)Boosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis Immunol Res 64 5356-455
[25]  
Khademi F(2011)Innate immune recognition of poxviral vaccine vectors Expert Rev Vaccines 10 41558-1965
[26]  
Derakhshan M(2014)Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu J Virol 88 e816-6633
[27]  
Yousefi-Avarvand A(2017)Immune signature of enhanced functional avidity CD8(+) T cells in vivo induced by vaccinia vectored vaccine Sci Rep 7 449-4444
[28]  
Tafaghodi M(2012)Immunogenicity and protective efficacy of heterologous prime-boost regimens with mycobacterial vaccines and recombinant adenovirus- and poxvirus-vectored vaccines against murine tuberculosis Int J Infect Dis 16 1957-1028
[29]  
Soleimanpour S(2005)Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers J Immunol 174 6626-839
[30]  
Dalmia N(2005)Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens Vaccine 23 4441-57